疫情就是命令,防控就是責(zé)任。在全國上下一盤棋、集中力量抗擊新冠病毒感染肺炎疫情的這段時間里,深圳市億立方生物技術(shù)有限公司(簡稱億立方,下同)作為國家級高新技術(shù)企業(yè)第一時間響應(yīng)黨中央號召,由投入“抗疫阻擊戰(zhàn)”的工作中,以每天24小時三班倒的形式奮戰(zhàn)在一線針對新型冠狀病毒鑒別難以及不同層級臨床單位使用的問題,從不同角度出發(fā),開發(fā)出最適宜性的產(chǎn)品。至今開發(fā)了5個新型冠病毒檢測試劑,并積極向疫區(qū)捐贈,得到各級政府的高度認(rèn)可,被列入國家級抗疫企業(yè)名單,并獲得興業(yè)銀行深圳分行2000萬元“抗疫貸”支持!抗疫期間億立方還收到了國家藥監(jiān)局批準(zhǔn)的百日咳酸核檢測試劑注冊證,屬于我國首個百咳核酸檢測試劑,填補了國內(nèi)百日咳核酸檢測的空白,為我國百日咳防控以及臨床診療作出了重大貢獻,億立方自成立來公司黨員同志始終沖鋒在前,充分彰顯了共產(chǎn)黨員在困難面前勇?lián)厝蔚某跣摹?/div>
Date:2020-03-03Tags:1.5 hours!ONE STEP screening of 18 respiratory pathogens!We cooperation with Youjiang Medical Univer
The technical cooperation between Youjiang MedicalUniversityfor Nationalities and Shenzhen high tech enterprises is the scientific research result of the joint anti epidemic of science and technology of both sides, which is conducive to the common development of science and technology of both sides. As the anti epidemic achievement of Youjiang MedicalUniversityfor nationalities, it is also an anti epidemic emergency product with independent intellectual property rights in Guangxi. It has great clinical significance and social value, and will effectively solve the problem of diagnosis and differential diagnosis of new coronavirus pneumonia and related respiratory infectious diseases in Guangxi and even the whole country. As China China ASEAN China one belt, one road to Guangxi, has become an important part of the "one belt and one way" initiative. As the bridgehead of China ASEAN, Guangxi has developed the most suitable anti epidemic products to support ASEAN countries. It will help enhance Guangxi's international influence as a China ASEAN bridgehead and enhance the friendly feelings of red city, as a revolutionary old area, to the international community's warm blood assistance.
Date:2020-03-03Tags:百日咳全球再現(xiàn),小嬰兒深受其害!新冠時期該如何應(yīng)對?
喜訊!經(jīng)過長期攻堅和不懈努力,深圳市億立方生物技術(shù)有限公司于2月14日,獲得國內(nèi)首個百日咳桿菌核酸檢測試劑盒的注冊許可(國械注準(zhǔn) 20203400152)。本產(chǎn)品的上市,解決了百日咳從50年代初期高發(fā)到80年代計劃免疫后百日咳被有效控制,再到近年來“百日咳再現(xiàn)”70年沒有核酸檢測的空白,為我國嬰幼兒帶來福音!也是防控新冠肺炎疫情的又一有利武器。
Date:2020-02-26Tags:重大喜訊!我司百日咳核酸檢測產(chǎn)品全國首發(fā)獲
重大喜訊!我司百日咳核酸檢測產(chǎn)品全國首發(fā)獲
Date:2020-02-20Tags:新型冠狀病毒、流感、鐘南山院士
鐘南山院士在廣東省舉行的發(fā)布會上指出目前新冠疫情防控所面臨的兩個亟待解決的重要問題,第一必須把新冠肺炎患者和正常人分開,第二把新冠肺炎病毒感染者和流感病毒感染者分開,否則人傳人不會停止。